Click a link below to view the mailing archive as if it had been sent to you.
| 2023-06-30 12:15 | | 9 Highly Anticipated FDA Decisions in Second Half of 2023 and more... |
| 2023-06-30 00:15 | | AbbVie, Genmab Bi-Specific Lymphoma Data Tee Up Potential Challenge to Roche Drug and more... |
| 2023-06-29 12:15 | | Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments and more... |
| 2023-06-29 00:15 | | FTC proposes updates to merger review that could slow healthcare dealmaking and more... |
| 2023-06-28 12:15 | | 10 clinical trials to watch in the second half of 2023 and more... |
| 2023-06-28 00:15 | | Lilly forks over $2.4M to settle federal agency's age discrimination lawsuit and more... |
| 2023-06-27 12:15 | | Diabetes Tech: A Catalyst Rich Sector with a Dazzling Future and more... |
| 2023-06-27 00:15 | | Shionogi Buys Qpex Biopharma for $140M, Expands Antimicrobial Pipeline and more... |
| 2023-06-26 12:15 | | 5 FDA decisions to watch in the third quarter and more... |
| 2023-06-26 00:15 | | Boehringer's new data drop shows 19% weight loss for phase 2 obesity prospect and more... |
| 2023-06-23 12:15 | | Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month? and more... |
| 2023-06-23 00:15 | | FDA Approves Sarepta’s Gene Therapy for Duchenne Muscular Dystrophy and more... |
| 2023-06-22 12:15 | | GE HealthCare partners with J&J to push spine imaging system and more... |
| 2023-06-22 00:15 | | PhRMA sues Biden administration over Medicare drug price negotiations and more... |
| 2023-06-21 12:15 | | GSK says RSV vaccine for older adults provides protection over two seasons and more... |
| 2023-06-21 00:15 | | Senators offer legislation to address drug shortages, supply chain problems and more... |
| 2023-06-20 12:15 | | Lilly makes fresh bet on IL-17 with $2.4B acquisition of Dice Therapeutics and more... |
| 2023-06-19 12:15 | | BMS Follows Merck’s Lead, Sues Government Over Drug Pricing Negotiation and more... |
| 2023-06-16 12:15 | | AbbVie's Skyrizi posts ulcerative colitis win in maintenance study, teeing up FDA nod and more... |
| 2023-06-16 00:15 | | Sandoz targets barriers to biosimilar accessibility with latest initiative and more... |
| 2023-06-15 12:15 | | Merck secures Bridion patent protection through January 2026 and more... |
| 2023-06-15 00:15 | | Pfizer refiles Seagen deal paperwork with regulators and more... |
| 2023-06-14 12:15 | | Biogen teams with NeuroSense to explore ALS neurofilament biomarker and more... |
| 2023-06-14 00:15 | | 4 ways Sanofi is using AI to power pharma innovations and more... |
| 2023-06-13 12:15 | | Biotech M&A is picking back up - here are the latest deals and more... |
| 2023-06-13 00:15 | | Johnson & Johnson inks another Stelara patent settlement, this time with Alvotech and Teva and more... |
| 2023-06-12 12:15 | | Novartis to acquire kidney disease biotech Chinook for up to $3.5B and more... |
| 2023-06-12 00:15 | | FDA panel backs full approval for Eisai, Biogen Alzheimer’s drug and more... |
| 2023-06-09 12:15 | | AstraZeneca Teams Up With Startup Quell in Type 1 Diabetes, IBD Cell Therapy Pact and more... |
| 2023-06-09 00:15 | | FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV and more... |
| 2023-06-08 12:15 | | National cancer group reports widespread chemo shortages, calls on government and industry to help resolve them and more... |
| 2023-06-08 00:15 | | Ahead of key meeting, FDA appears open to full approval of Alzheimer’s drug Leqembi and more... |
| 2023-06-07 12:15 | | Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices and more... |
| 2023-06-07 00:15 | | ASCO: Merck's Keytruda trips in EGFR lung cancer as Roche's Tecentriq fails in kidney cancer and more... |
| 2023-06-06 12:15 | | BIO: Jazz is auditioning new bandmates in an M&A market ripe with talent and more... |
| 2023-06-06 00:15 | | Pricing law jeopardizes post-approval R&D process for cancer pills: analysis and more... |
| 2023-06-05 12:15 | | AstraZeneca study points to new uses for targeted cancer drug Enhertu and more... |
| 2023-06-05 00:15 | | ASCO: Seagen's top-selling drug under threat as Bristol Myers' Opdivo beats Adcetris in lymphoma and more... |
| 2023-06-02 12:15 | | Novartis drug helps stop breast cancer’s return in large study and more... |
| 2023-06-02 00:15 | | Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology and more... |
| 2023-06-01 12:15 | | FDA clears narrow use of Lynparza in prostate cancer, continuing ‘shift’ on PARP drugs and more... |
| 2023-06-01 00:15 | | FDA approves Pfizer’s RSV vaccine for older adults and more... |
